BL

BioLineRx

- NASDAQ:BLRX
Last Updated 2024-04-16
  • Systematically Identifying, In- Licensing and Validating Promising Therapeutic Candidates

  • Locations

    • Jerusalem Yerushalayim

  • Total Funding (USD)

    100.9 million

  • Industries

    Real Estate, Mobile Apps, Video Games, Software, Internet

  • Acquisitions (1)

    • Agalimmune (2017)

  • Security

    Type:
    CUSIP: 09071M205
    ISIN: US09071M2052
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo